Lukas Käsmann

German Cancer Research Center — Germany

Medicine · Health Sciences

20h-index1.5kcitations198works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(66), Lung Cancer Treatments and Mutations(65), Cancer Immunotherapy and Biomarkers(47), Lung Cancer Research Studies(46), Radiomics and Machine Learning in Medical Imaging(25)

Publications198 total

Hyperbaric oxygen therapy for chronic radiotherapy‐related adverse effects: A clinically focused review
CA A Cancer Journal for Clinicians·2025Open Access
Long-term outcomes and patterns of failure after empiric SBRT for presumed early-stage lung tumors
Frontiers in Oncology·2025Open Access
Quality of life in cancer patients at the end of radiotherapy compared to a general population sample in Germany
International Journal of Cancer·2025· 1 citedOpen Access
1398P LIONESS study: A personalised cell-free tumour DNA analysis for residual disease detection and recurrence monitoring in head and neck squamous cell carcinoma
Annals of Oncology·2025
Complementary and Alternative Medicine (CAM) Use in Patients Undergoing Radiotherapy: Sex-specific Prevalence and Associations of Use Based on the S3 Guideline Complementary Medicine in Oncology Questionnaire
In Vivo·2025Open Access
Interactive Tumor Board Simulation - Development of a New Student-Led Teaching Format
International Journal of Radiation Oncology*Biology*Physics·2025
Empiric stereotactic body radiotherapy for presumed early-stage lung cancer
Strahlentherapie und Onkologie·2025· 1 citedOpen Access
Enhancing the intraoperative identification of high-grade patterns in invasive lung adenocarcinoma via radiomics
Translational Lung Cancer Research·2025Open Access
Assessing ChatGPT’s Educational Potential in Lung Cancer Radiotherapy From Clinician and Patient Perspectives: Content Quality and Readability Analysis
JMIR Cancer·2025Open Access
Early recovery of leukocyte subsets is associated with favorable progression-free survival in patients with inoperable stage II/III NSCLC after multimodal treatment: a prospective explorative study
Radiation Oncology·2025Open Access
191P: Patient-reported versus clinician-reported outcomes in patients undergoing concurrent chemoradiotherapy and durvalumab maintenance for inoperable stage III NSCLC: Insights from the prospective PRECISION Study
Journal of Thoracic Oncology·2025Open Access
115P: Exploring hypofractionated thoracic radiotherapy in stage IV NSCLC: Insights from a real-world retrospective study
Journal of Thoracic Oncology·2025Open Access
Identification and validation of crotonylation-related diagnostic markers for lung adenocarcinoma via weighted correlation network analysis and machine learning
Translational Lung Cancer Research·2025· 2 citedOpen Access
Gadolinium oxide nanoparticles as a multimodal contrast enhancement agent for pre-clinical proton imaging
Physics in Medicine and Biology·2025· 1 citedOpen Access
Therapeutic Outcomes and Toxicity of Stereotactic Body Radiotherapy (SBRT) and Stereotactic Radiosurgery (SRS) in Metastatic Anaplastic Thyroid Cancer: A Systematic Review and Meta-Analysis
2024Open Access
Assessing ChatGPT's educational potential in lung cancer radiotherapy: A readability, clinician, and patient evaluation (Preprint)
2024Open Access
Dosimetric Predictors of Acute Radiation Pneumonitis and Esophagitis in Hypofractionated Thoracic Irradiation of Non-Small Cell Lung Cancer Patients With Poor Prognostic Factors
Advances in Radiation Oncology·2024· 1 citedOpen Access
Langzeitergebnisse der IMRT vs. 3D-konformalen Radiotherapie beim lokal fortgeschrittenem, inoperablem nicht-kleinzelligem Lungenkarzinom (NSCLC)
Strahlentherapie und Onkologie·2024· 1 citedOpen Access
Prognostic significance of pretreatment PET parameters in inoperable, node-positive NSCLC patients with poor prognostic factors undergoing hypofractionated radiotherapy: a single-institution retrospective study
EJNMMI Reports·2024· 2 citedOpen Access
Tumor board simulation improves interdisciplinary decision-making in medical students
Journal of Cancer Research and Clinical Oncology·2024· 1 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Farkhad Manapov(20), Claus Belka(20), Chukwuka Eze(19), Dirk Rades(14), Julian Taugner(13), Olarn Roengvoraphoj(11), Amanda Tufman(11), Stefan Janssen(10), M. Dantes(6), Monika Karin(6), Daniel F. Fleischmann(6), Matthias Mäurer(6), Nina-Sophie Schmidt-Hegemann(5), Minglun Li(5), Niels Reinmuth(5), Josefine Rauch(4), Louisa Bolm(4), K. Gennen(4), Maximilian Niyazi(4), Sonia Ziegler(4)